Chia Tai Tianqing approved the third high-end generic drug this year, pointing to Merck's heavy variety

Recently, Chia Tai Tianqing Pharmaceutical Group's application for the imitation of aprepitant capsules in category 4 was approved, making it the second domestic pharmaceutical company to be approved for the product and deemed to have been reviewed.

Figure 1: Details of approved products

Source: NMPA official website

Aprepitant is mainly used to prevent acute and delayed nausea and vomiting during the initial and repeated treatment of highly emetic anti-tumor chemotherapy.

Figure 2: Sales of Aprepitant Capsules

Source: Mi Nei.

According to data from Minai.

Table 1: High-end generic drugs approved by Chia Tai Tianqing Pharmaceutical Group since 2021

Source: Meinenet MED2.

Since 2021, CP Tianqing Pharmaceutical Group has approved 3 high-end generic drugs (Category 3, Category 4) for listing.

Table 2: Chia Tai Tianqing Pharmaceutical Group's listing applications under review since 2018

Source: Meinenet MED2.

Chia Tai Tianqing Pharmaceutical Group’s applications for the listing of generic drugs under review from 2018 to the present are all declared according to the new classification.